Amylyx Pharmaceuticals
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

55 Cambridge Pkwy Ste 6W, Cambridge, Mas...

Phone Number

(617) 682-0917

Revenue

-

Stock Symbol

AMLX

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and other neurodegenerative diseases. The company's therapeutic, AMX0035, targets the neuroinflammation and nerve cell death that characterize these diseases. AMX0035 is a proprietary combination of existing compounds that act synergistically to prevent cell death and neurotoxic inflammation in multiple preclinical models.Explore more
Amylyx Pharmaceuticals's Social MediaSIC Code 28,283NAICS Code 54,541Ticker NASDAQ: AMLXShow more

Amylyx Pharmaceuticals Org Chart

Justin Klee, Co-Chief Executive Officer at Amylyx Pharmaceuticals
United States flag for contact location.

Co-Chief Executive Officer

PhoneEmail
LA
United States flag for contact location.

Chief Human Resources Officer

PhoneEmail
James Frates, Chief Financial Officer at Amylyx Pharmaceuticals
United States flag for contact location.

Chief Financial Officer

PhoneEmail
Camille Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MM
United States flag for contact location.

Senior VP, Human Resources & Talent Acquisiti...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Amylyx Pharmaceuticals

Compare insights from companies similar to Amylyx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Amylyx Pharmaceuticals

51-200
Public
$542.9M
2013
$30.4M
51-200
Private
$150M
2016
Kasper Roet, Founder and Chief Executive Officer of QurAlis at QurAlis
Kasper RoetFounder and CEO of QurAlis
$27M
51-200
Private
<$5M
1999
EL
Emer LeahyPresident & CEO
$25.4M
11-50
Private
<$5M
2007
IT
Irene TennantRegulatory Affairs Vice President, Clinical Development
$12.2M
51-200
Private
<$5M
2016
SS
Stacy SinibaldiQA Associate Director, Research & Development
$7.2M
51-200
Private
$40.3M
2010
Manish Lavhale, Managing Director at Pharmazz
Manish LavhaleManaging Director
<$5M
51-200
Public
$140.3M
2013
Mark Mortenson, Co-Founder & Chief Technology Officer at Clene Nanomedicine
Mark MortensonCo-Founder & Chief Technology Officer
Illustration of an envelope

Amylyx Pharmaceuticals Tech Stack

A closer look at the technologies used by Amylyx Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding Amylyx Pharmaceuticals

What is Amylyx Pharmaceuticals's stock symbol?
Amylyx Pharmaceuticals's stock symbol is AMLX
What is Amylyx Pharmaceuticals's official website?
Amylyx Pharmaceuticals's official website is www.amylyx.com
What is Amylyx Pharmaceuticals's SIC code?
Amylyx Pharmaceuticals's SIC: 28,283
What is Amylyx Pharmaceuticals's NAICS code?
Amylyx Pharmaceuticals's NAICS: 54,541
How many employees does Amylyx Pharmaceuticals have?
Amylyx Pharmaceuticals has 51-200 employees
What industry does Amylyx Pharmaceuticals belong to?
Amylyx Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Amylyx Pharmaceuticals competition?
Amylyx Pharmaceuticals top competitors include: Pharmazz, QurAlis, Clene Nanomedicine, PsychoGenics
What technology does Amylyx Pharmaceuticals use?
Some of the popular technologies that Amylyx Pharmaceuticals uses are: CSC Corporate Domains, Drupal, reCAPTCHA, Microsoft SharePoint
Who is the CFO of Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals's CFO is James Frates
What does Amylyx Pharmaceuticals do?

Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and other neurodegenerative diseases. The company's therapeutic, AMX0035, targets the neuroinflammation and nerve cell death that characterize these diseases. AMX0035 is a proprietary co... mbination of existing compounds that act synergistically to prevent cell death and neurotoxic inflammation in multiple preclinical models.Read More

What are Amylyx Pharmaceuticals social media links?
Amylyx Pharmaceuticals Linkedin page Amylyx Pharmaceuticals Twitter page Amylyx Pharmaceuticals Facebook page
Who invested in Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals has 15 investors including ALS Investment Fund, Morningside Venture Capital, ALS Association and ALS Finding a Cure.
Is Amylyx Pharmaceuticals a public company?
Yes, Amylyx Pharmaceuticals is a public company and is traded under the symbol AMLX
See more information about Amylyx Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.